Tag: lead time bias

Neko Health whole body scans

The return of marketing hype for “whole body scans”…now with AI!

Two decades ago, I cut my skeptical teeth countering advertising for whole body scans by companies making extravagant promises for their products. This particular medical fad faded for a while, but now it's back with a vengeance...with AI! Looking at these products, what I see is basically the quackery that is functional medicine on steroids and powered by AI.

/ July 10, 2023

We are not “losing the war on cancer” (belated 2021 edition)

The narrative we hear time and time again is that we are "losing the war on cancer". The latest cancer statistics show that this narrative is not true.

/ July 19, 2021

Cancer Deaths Continue to Decline

Overall cancer incidence has been stable in women and declining steadily in men. Changes in specific cancers reflect known risk factors and the effect of screening methods. What is not seen in this data is any mysterious increase in any specific cancer or cancers overall. 

/ January 10, 2018

Contrary to what we are frequently told, we are not “losing the war on cancer”

A common narrative about cancer is that we are making no progress in our fight against it. Fortunately, the actual data do not agree. Yes, too many people still die of cancer and progress is slow, but it's not correct to claim that we are losing the war on cancer.

/ April 3, 2017

When science- and evidence-based guidelines conflict with patient wishes: What’s a doc to do?

We use the term "science-based medicine" (SBM) because medicine isn't a science. The best medicine, however, is based in science. Patient values are also important, but what is a science-based doctor to do when SBM conflicts with what a patient or family wants?

/ October 3, 2016

The uncertainty surrounding mammography continues

Mammography is a topic that, as a breast surgeon, I can’t get away from. It’s a tool that those of us who treat breast cancer patients have used for over 30 years to detect breast cancer earlier in asymptomatic women and thus decrease their risk of dying of breast cancer through early intervention. We have always known, however, that mammography is an...

/ July 13, 2015

Once more into the screening breach: The New York Times did not kill your patient

Dr. George Lombardi thinks that he could have saved a patient from dying of prostate cancer if a prostate specific antigen test had been done. Is he right? Probably not.

/ March 25, 2013

The mammography wars heat up again (2012 edition)

One issue that keeps coming up time and time again for me is the issue of screening for cancer. Because I’m primarily a breast cancer surgeon in my clinical life, that means mammography, although many of the same issues come up time and time again in discussions of using prostate-specific antigen (PSA) screening for prostate cancer. Over time, my position regarding how...

/ August 6, 2012

Cancer care in the U.S. versus Europe: Is more necessarily better?

The U.S. is widely known to have the highest health care expenditures per capita in the world, and not just by a little, but by a lot. I’m not going to go into the reasons for this so much, other than to point out that how to rein in these costs has long been a flashpoint for debate. Indeed, most of the...

/ April 16, 2012

Are one in three breast cancers really overdiagnosed and overtreated?

Screening for disease is a real pain. I was reminded of this by the publication of a study in BMJ the very day of the Science-Based Medicine Conference a week and a half ago. Unfortunately, between The Amaz!ng Meeting and other activities, I was too busy to give this study the attention it deserved last Monday. Given the media coverage of the...

/ July 20, 2009